RiverVest Venture Management LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed October 30, 2024), RiverVest Venture Management LLC reported 3 stock positions worth $6.8 million. Its top holding was Reneo Pharmaceuticals at 63.0% of the portfolio, followed by Spruce Biosciences (SPRB, 20.4%) and Xilio Therapeutics (XLO, 16.6%). Compared with Q2 2024, it sold out of 1. The biggest sale was an exit from Vapotherm.
- Most Recent 13F
- Q3 2024
- Location
- St. Louis, MO
- CIK
- 0001812549
- Portfolio Value
- $6.8M (Q3 2024)
- SEC Filing
- 0001104659-24-112539 ↗ filed Oct 30, 2024
Holdings Value
Holdings 3 stocks · $6.8M
| RENEO PHARMACEUTICALS INC | 63.00% | 2,534,220 | $4.3M | No change |
| SPRB Spruce Biosciences Inc. | 20.39% | 2,936,281 | $1.4M | No change |
| XLO Xilio Therapeutics Inc. | 16.60% | 1,441,444 | $1.1M | No change |
Portfolio Sells Q2 2024 → Q3 2024
| VAPOTHERM INC | Sold out | 0.00% | −1.65 |
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||